3.4 A PRESSURE-INDEPENDENT ARTERIAL REMODELLING AND AORTA DILATATION IN TREATED PATIENTS WITH FABRY DISEASE
Purpose: Fabry disease is a deficiency of lysosomal enzyme α-galactosidase A leading to accumulation of glycosphyngolipids in cardiac and vascular tissues. After long-term enzyme replacement treatment, we described a continuous vascular hypertrophy whereas the aortic stiffness was paradoxically decr...
Main Authors: | C. Collin, M. Bensalah, H. Beaussier, D.P. Germain, E. Bozec, E. Mousseaux, S. Laurent, P. Boutouyrie |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2009-12-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125927364/view |
Similar Items
-
Ascending aorta dilatation common feature which correlate with left ventricular hypertrophy in fabry disease
by: Germain Dominique, et al.
Published: (2011-02-01) -
Aortic arch stiffness in Fabry disease
by: Bensalah Zoubir M, et al.
Published: (2013-01-01) -
01.04 NON INVASIVE EVALUATION OF ARTERIAL REMODELING IN PATIENTS WITH FABRY DISEASE AFTER ENZYME REPLACEMENT THERAPY
by: C.C. Collin, et al.
Published: (2007-08-01) -
P1.33 DETERMINANTS OF THORACIC AORTA REMODELING BY USING CMR AND CAROTIDO-FEMORAL APPLANATION TONOMETRY
by: M.Z.B. Bensalah, et al.
Published: (2013-11-01) -
P4.04 LONG-TERM REDUCTION IN AORTIC STIFFNESS IN HYPERTENSIVE PATIENTS IS PARTLY INDEPENDENT OF MBP REDUCTION
by: C. Collin, et al.
Published: (2009-12-01)